亿胜生物科技(01061)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01061 亿胜生物科技

休市中 09-25 16:08:12

2.085

-0.050

-2.34%

最高2.165	最低2.085	成交量22.90万
今开2.105	昨收2.135	日振幅3.75%
总市值11.78亿	流通市值11.78亿	总股本5.65亿
成交额48.09万	换手率0.04%	流通股本5.65亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01061","market":"HK","secType":"STK","nameCN":"亿胜生物科技","latestPrice":2.085,"timestamp":1790323692505,"preClose":2.135,"halted":0,"volume":229000,"delay":0,"changeRate":-0.023419203747072518,"floatShares":565000000,"shares":565000000,"eps":0.561,"marketStatus":"休市中","change":-0.05,"latestTime":"09-25 16:08:12","open":2.105,"high":2.165,"low":2.085,"amount":480935,"amplitude":0.037471,"askPrice":2.175,"askSize":1000,"bidPrice":2.085,"bidSize":3000,"shortable":0,"etf":0,"ttmEps":0.468098,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":7,"adr":0,"listingDate":993571200000,"exchange":"SEHK","adjPreClose":2.135,"dividendRate":0.057554,"openAndCloseTimeList":[[1790299800000,1790308800000],[1790312400000,1790323200000]],"volumeRatio":0.7639745624711733,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01061","defaultTab":"news","newsList":[{"id":"1121760024","title":"亿胜生物科技回购25,000股股份，耗资约5.10万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121760024","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121760024?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:01","pubTimestamp":1789549309,"startTime":"0","endTime":"0","summary":"2026年9月16日，亿胜生物科技有限公司披露翌日披露报表，宣布于2026年9月16日在香港联交所场内购回25,000股股份，约占当日现有已发行股本的0.00443%。回购价范围介乎每股2.025港元至2.05港元，合共涉资约5.10万港元。本次交易完成后，公司已发行股本数目由564,939,000股降至564,914,000股，库藏股数量由2,067,000股增加至2,092,000股，合计股份总数仍为567,006,000股。公司同时表示，将在随后的30天暂缓进行任何新股发行或库藏股再出售或转让。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技回购25,000股股份，耗资约5.10万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643814","title":"亿胜生物科技(01061.HK)9月15日回购2.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643814","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667643814?lang=zh_cn&edition=full","pubTime":"2026-09-15 17:07","pubTimestamp":1789463224,"startTime":"0","endTime":"0","summary":"格隆汇9月15日丨亿胜生物科技(01061.HK)发布公告，2026年9月15日耗资4.68万港元回购2.3万股，回购价格每股2.02-2.045港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260915/32370412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185545567","title":"亿胜生物科技9月15日回购2.3万股，涉资约4.68万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185545567","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185545567?lang=zh_cn&edition=full","pubTime":"2026-09-15 16:45","pubTimestamp":1789461956,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年9月15日完成一笔股份回购交易。公司通过香港联交所场内回购23,000股普通股，占截至回购前公司已发行股本约0.00407%。每股回购价格介乎2.02港元至2.045港元，合计支付约46,810港元。本次回购完成后，公司已发行股份总数维持在567,006,000股，其中不包括库藏股的已发行股份数为564,939,000股，库藏股数为2,067,000股。公司此前于2026年5月26日通过购回授权，可在授权额度内回购最多56,700,600股，截至目前已合计回购2,067,000股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技9月15日回购2.3万股，涉资约4.68万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667651458","title":"亿胜生物科技(01061)9月14日斥资1.83万港元回购9000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667651458","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667651458?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:02","pubTimestamp":1789376568,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，该公司于2026年9月14日斥资1.83万港元回购9000股股份，每股回购价格为2.03-2.045港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143480537","title":"亿胜生物科技：9月14日回购9,000股，耗资约1.83万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143480537","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143480537?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:01","pubTimestamp":1789376505,"startTime":"0","endTime":"0","summary":"亿胜生物科技有限公司于2026年9月14日发布翌日披露报表，披露当日在香港联交所场内回购9,000股普通股，占当日回购前公司已发行股本总数的约0.00159%。本次回购的每股价格介于每股2.03港元至2.045港元之间，总耗资约18,325港元。回购完成后，公司已发行股本由564,971,000股减少至564,962,000股，而库藏股由2,035,000股增加至2,044,000股，总已发行股本仍维持在567,006,000股。公司声明，本次回购事项已获得董事会正式授权批准，相关程序严格遵守香港联交所证券上市规则及适用法律法规的规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技：9月14日回购9,000股，耗资约1.83万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178995014","title":"亿胜生物科技9月11日回购3.10万股股份，涉资约6.37万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178995014","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178995014?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:06","pubTimestamp":1789117581,"startTime":"0","endTime":"0","summary":"2026年9月11日，亿胜生物科技在香港联合交易所刊发翌日披露报表。公告显示，公司当日在香港联交所场内回购股份3.10万股，占回购前公司已发行股本约0.00549%，每股回购价为每股2.055港元，合计耗资约6.37万港元。回购完成后，公司已发行股份总数变动为564,971,000股，持作库存股份数为2,035,000股。公司表示，前述行为已严格遵守香港联交所证券上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技9月11日回购3.10万股股份，涉资约6.37万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666540675","title":"亿胜生物科技(01061.HK)9月11日耗资约6.37万港元回购3.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666540675","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666540675?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:05","pubTimestamp":1789117549,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170478644","title":"亿胜生物科技：9月10日回购6万股股份，耗资约12.42万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170478644","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170478644?lang=zh_cn&edition=full","pubTime":"2026-09-10 16:55","pubTimestamp":1789030543,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年9月10日发布公告，披露在香港联合交易所进行股份回购。公司当日回购普通股6万股，占回购前已发行股本约0.01062%，每股价格介乎2.06港元至2.08港元，此次回购涉资总额约12.42万港元。公司表示，回购授权于2026年5月26日获得通过，可购回股份总数为56,700,600股，截至目前已在香港联交所及其他交易所累计回购2,004,000股，占授权通过当日发行股本约0.35344%。公司确认回购事宜已遵守香港联合交易所有限公司证券上市规则及相关法例规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技：9月10日回购6万股股份，耗资约12.42万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666074566","title":"亿胜生物科技(01061.HK)9月10日斥资12.42万港元回购6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666074566","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666074566?lang=zh_cn&edition=full","pubTime":"2026-09-10 16:43","pubTimestamp":1789029814,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189331392","title":"亿胜生物科技9月1日回购6万股股份，总额约12.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189331392","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189331392?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:13","pubTimestamp":1788254027,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年9月1日发布公告称，该公司当日在香港联交所回购公司普通股60,000股。据公告，本次回购约占回购前已发行股本0.01062%，每股购回价介乎港币2.15元至2.18元，总金额为港币12.99万元。本次购回完成后，公司已发行股份数量从回购前的565,122,000股减少至565,062,000股，库藏股从1,884,000股增加至1,944,000股，总已发行股本仍为567,006,000股。公告显示，上述回购乃根据2026年5月26日股东大会通过的回购授权进行，授权总数为56,700,600股，截至公告日已累计回购1,944,000股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"亿胜生物科技9月1日回购6万股股份，总额约12.99万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837859","title":"亿胜生物科技(01061)9月1日斥资12.99万港元回购6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837859","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664837859?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:10","pubTimestamp":1788253825,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，于2026年9月1日斥资12.99万港元回购6万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139147935","title":"亿胜生物科技更新2026年8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1139147935","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139147935?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:32","pubTimestamp":1788251529,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年9月1日发布截至2026年8月31日的股份变动月报表。报告显示，公司本月无新增发行股份，整体股本维持稳定。根据公告，公司在报告期内进行了多笔股份回购，共计回购528,000股，回购价格介于每股2.265港元至2.3718港元之间。本月报告期内，并无因股份期权行使而增发或转换股份，公司根据此前于2023年6月9日股东大会通过的购股权计划，仍可发行或自库存转让最多57,064,900股。公司确认，截至报告期末已符合适用的公众持股量规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175879961","title":"亿胜生物科技回购4万股，耗资约9.06万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175879961","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175879961?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:11","pubTimestamp":1787562697,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年8月24日发布公告，披露当日于香港联交所场内回购40,000股普通股，占该次回购前已发行股份的约0.00708%。本次回购每股价格最高为2.28港元、最低为2.25港元，合计耗资约90,600港元。公司确认上述回购股份将被持作库存股份。本次交易完成后，公司已发行股份数目为565,122,000股，库存股份数目为1,884,000股，合计股份总数为567,006,000股。公告显示，亿胜生物科技已就上述回购事项严格遵守香港联交所证券上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技回购4万股，耗资约9.06万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224118","title":"亿胜生物科技(01061)8月24日斥资9.06万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224118","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661224118?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:01","pubTimestamp":1787562109,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，于2026年8月24日斥资9.06万港元回购4万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189870777","title":"亿胜生物科技：8月21日回购1.80万股，耗资约4.14万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189870777","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189870777?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:56","pubTimestamp":1787306194,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年8月21日公告称，公司在香港联交所场内回购股份。是次回购数量为1.80万股普通股，对应已发行股本约0.00318%。每股回购价格为2.30港元，支付总金额约4.14万港元。回购完成后，公司已发行股本由2026年8月19日的565,180,000股变更为565,162,000股，库藏股数由1,826,000股增加至1,844,000股。截至目前，公司已于市场回购1,844,000股，占授权通过时已发行股本的0.32522%。公司确认已遵守香港联合交易所有限公司证券上市规则及其他相关法律法规的规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技：8月21日回购1.80万股，耗资约4.14万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661261812","title":"亿胜生物科技(01061.HK)8月21日斥资4.14万港元回购1.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661261812","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661261812?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:50","pubTimestamp":1787305800,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100944434","title":"亿胜生物科技8月19日回购2万股，耗资46,000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100944434","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100944434?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:52","pubTimestamp":1787129570,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年8月19日发布翌日披露报表，公告显示公司当日于香港联交所回购普通股20,000股，占回购前已发行股本0.00354%。本次回购每股价格为2.3港元，合计耗资46,000港元。据公告，购回授权于2026年5月26日获通过，授权可回购股数为56,700,600股，截至目前公司已累计回购1,826,000股，占购回授权通过当日已发行股本的0.32204%。公司确认已遵守香港联交所上市规则及相关法例的规定。本公告由公司董事方海洲签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技8月19日回购2万股，耗资46,000港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660727445","title":"亿胜生物科技(01061.HK)8月19日斥资4.6万港元回购2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660727445","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660727445?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:48","pubTimestamp":1787129309,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182437863","title":"亿胜生物科技2026年中期营收7.85亿港元，经调整净利润1.11亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182437863","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182437863?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:53","pubTimestamp":1786524803,"startTime":"0","endTime":"0","summary":"截至2026年6月30日止六个月，亿胜生物科技录得营收7.85亿港元，同比减少10.5%。经调整净利润为1.11亿港元，同比下降32.2%。报告期内，毛利约为6.56亿港元，毛利率约83.66%，较上年同期下降5.12个百分点。行政开支增至约1.27亿港元，在营收中的占比约16.17%，同比有所上升。按分部划分，眼科业务录得营收3.67亿港元，同比下降12.0%；外科业务营收3.41亿港元，同比下滑24.0%；医疗保健及伙伴服务营收7,630万港元，较上年同期增长约646.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"亿胜生物科技2026年中期营收7.85亿港元，经调整净利润1.11亿港元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658978941","title":"亿胜生物科技：上半财年营收7.85亿港元，同比增长-10.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658978941","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658978941?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:51","pubTimestamp":1786524660,"startTime":"0","endTime":"0","summary":"南财智讯8月12日电，亿胜生物科技（01061.HK）公告，截至2026年6月30日止六个月，公司实现收益784694000港元，折合7.85亿港元；上年同期为876535000港元，同比下降10.48%。可报告分部溢利为190762000港元，折合1.91亿港元；上年同期为242068000港元。本公司拥有人应占每股盈利为19.53港仙，上年同期为28.82港仙。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608123839205731.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608123839205731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.essexbio.com","stockEarnings":[{"period":"1week","weight":-0.0795},{"period":"1month","weight":-0.0815},{"period":"3month","weight":-0.2197},{"period":"6month","weight":-0.3957},{"period":"1year","weight":-0.5748},{"period":"ytd","weight":-0.4213}],"compareEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":-0.0446},{"period":"3month","weight":0.0811},{"period":"6month","weight":-0.0177},{"period":"1year","weight":-0.0746},{"period":"ytd","weight":-0.0437}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"亿胜生物科技有限公司是一家主要从事生产及销售治疗体表创伤和眼部损伤生物药品的投资控股公司。该公司通过三个业务分部进行运营。外科分部主要从事开发、制造及销售贝复济液体制剂、贝复济冻干粉及贝复新凝胶以及其他产品。眼科分部从事开发、制造与销售贝复舒滴眼液、贝复舒眼用凝胶及贝复舒单剂量滴眼液以及其他产品。提供服务分部主要从事提供医疗科技电子平台相关医疗服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.733333,"avgChangeRate":0.036326},{"month":2,"riseRate":0.6,"avgChangeRate":0.051587},{"month":3,"riseRate":0.533333,"avgChangeRate":0.042832},{"month":4,"riseRate":0.466667,"avgChangeRate":0.031989},{"month":5,"riseRate":0.4,"avgChangeRate":-0.012147},{"month":6,"riseRate":0.4,"avgChangeRate":0.022585},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.0304},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.005022},{"month":9,"riseRate":0.5,"avgChangeRate":0.027327},{"month":10,"riseRate":0.333333,"avgChangeRate":0.013913},{"month":11,"riseRate":0.466667,"avgChangeRate":0.008936},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.01898}],"exchange":"SEHK","name":"亿胜生物科技","nameEN":"ESSEX BIO-TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亿胜生物科技(01061)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亿胜生物科技(01061)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亿胜生物科技,01061,亿胜生物科技股票,亿胜生物科技股票老虎,亿胜生物科技股票老虎国际,亿胜生物科技行情,亿胜生物科技股票行情,亿胜生物科技股价,亿胜生物科技股市,亿胜生物科技股票价格,亿胜生物科技股票交易,亿胜生物科技股票购买,亿胜生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亿胜生物科技(01061)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亿胜生物科技(01061)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}